Source:http://linkedlifedata.com/resource/pubmed/id/21151685
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:dateCreated |
2010-12-14
|
| pubmed:abstractText |
To evaluate vasomotor symptoms and soy and hormone therapy use in women who had previously participated in the Soy Estrogen Alternative (SEA) study, a trial conducted to compare the effects of soy protein supplements containing differing levels of isoflavones on menopausal symptoms, chronic disease risk factors, and health-related quality of life in perimenopausal and postmenopausal women.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:status |
PubMed-not-MEDLINE
|
| pubmed:issn |
1179-1411
|
| pubmed:author | |
| pubmed:issnType |
Electronic
|
| pubmed:volume |
2
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
381-6
|
| pubmed:year |
2010
|
| pubmed:articleTitle |
Soy use and vasomotor symptoms: Soy Estrogen Alternative follow-up study.
|
| pubmed:affiliation |
Division of Public Health Sciences, Wake Forest University Health Sciences, Winston-Salem, North Carolina. mvitolin@wfubmc.edu
|
| pubmed:publicationType |
Journal Article
|